Finnegan

1. Lilly Targets Actavis In Latest Cymbalta Patent Suit

Wednesday, Nov 19, 2008

Eli Lilly and Co. added a fifth generic drugmaker to its bid to block competing versions of its antidepressant Cymbalta Tuesday, suing Actavis Elizabeth LLC over a patent for the blockbuster drug less than a week after filing four similar suits.

2. Inventor Fights Realtors Over Listings Patent

Friday, Nov 14, 2008

Attorneys for an inventor who has sued Homestore Inc. for patent infringement fought the real-estate listings company's bid for summary judgment of anticipation and obviousness in federal court Friday, saying the defendant's argument ignored contrary evidence as well as the court's claim constructions.

3. Rambus Hits Nvidia, Others With ITC Complaint

Friday, Nov 07, 2008

Rambus Inc. has lodged a complaint with the U.S. International Trade Commission targeting Nvidia Corp. and several other companies, seeking to block the importation of products that allegedly infringe nine Rambus patents related to semiconductor chips with synchronous dynamic random access memory controllers.

4. Wyeth Settles With 4th Drug Co. Over Generic Effexor

Thursday, Nov 06, 2008

A federal judge has approved a consent judgment between Wyeth and Anchen Pharmaceutical Inc., the fourth generic drug maker the pharmaceutical giant has settled with over its popular antidepressant Effexor XR.

5. Fed. Circ. Upholds Rejection Of Cancer Patent Claim

Friday, Oct 31, 2008

A patent application describing a method for treating a rare form of cancer was appropriately rejected for lacking adequate written description because the patent's specification described only a single antibody, while the contested patent claim involved a much larger grouping of antibodies, the U.S. Court of Appeals for the Federal Circuit has ruled.

6. AstraZeneca Sues Handa Again Over Seroquel XR

Wednesday, Oct 29, 2008

AstraZeneca Pharmaceuticals LP hit Handa Pharmaceuticals LLC with a second infringement suit in three months Tuesday over its bid to produce a generic version of Seroquel XR.

7. LG Comes Out Clean From Whirlpool Patent Suit

Monday, Oct 27, 2008

A federal appeals court has handed South Korea’s LG Electronics Inc. a victory in a drawn-out patent suit brought by Whirlpool Corp. over its two washing machine patents.

8. Judge Hands Medtronic Win On Rapid-Exchange Bar

Wednesday, Oct 22, 2008

Just a week after Abbott Cardiovascular Systems Inc. won a yearlong interim extension of a 1995 angioplasty patent, a judge has ruled that a 2000 injunction preventing Medtronic Inc. from selling any infringing rapid-exchange catheter will end as of Oct. 29, the patent's original expiration date.

9. Fed. Circ. Reverses Verisign Credit Card Patent Claims

Monday, Oct 20, 2008

An appellate court has reversed in part a summary judgment granted to Verisign Inc. and other defendants in a feud with Net MoneyIN Inc. over patents for encryption techniques used to secure credit card transactions over the Internet.

10. Dish To Pay $104M After High Court Refuses Appeal

Monday, Oct 06, 2008

Dish Network Corp. will pay TiVo Inc. about $104 million in damages after the U.S. Supreme Court refused to hear an appeal of a ruling finding the company infringed TiVo's digital video recorder technology.

11. Abbott Unit's Injunction Bid Denied In Stent Spat

Tuesday, Sep 30, 2008

A federal judge denied a permanent injunction bid from an Abbot Laboratories subsidiary that took aim at Medtronic Inc.'s Endeavor drug-eluting stent, the latest development in a long-running battle over stent patents.

12. Eli Lilly Sues Teva Again Over Gemzar ANDA

Monday, Sep 29, 2008

Eli Lilly & Co. has filed another infringement complaint against Teva Pharmaceuticals USA Inc. over efforts to make a generic version of Lilly's cancer treatment Gemzar.

13. Medtronic, Abbott Fight For Judgment In Stent Feud

Wednesday, Sep 24, 2008

Medtronic Inc. and Abbott Laboratories Inc. faced off in federal court Wednesday, each vying for summary judgment on the issue of whether certain claims of two stent patents were invalid or obvious as anticipated by prior art.

14. ITC Rules Against Tate & Lyle In Sucralose Probe

Tuesday, Sep 23, 2008

The U.S. International Trade Commission has initially cleared most of the companies British sugar producer Tate & Lyle PLC accused of infringing patents for technology used to make sucralose, a leading sweetener in the U.S.

15. It Ain’t Easy Being Green

Friday, Sep 19, 2008

The use of eco-conscious terms is now so prevalent that it is almost inevitable that the U.S. Patent and Trademark Office will object in some manner to an application containing such a term on the grounds that it is merely descriptive and does not serve to identify the source of a product or service, says Lawrence R. Robins of Finnegan, Henderson, Farabow, Garrett & Dunner LLP, and Katherine Staba.

16. ITC Wades Into Wii Debate

Thursday, Sep 18, 2008

The U.S. International Trade Commission has decided to look into allegations that Nintendo Co. has violated the patents owned by a Maryland company with its hugely popular Wii videogame system.

17. 2nd Circ. Won't Rehear Nokia Dispute: InterDigital

Wednesday, Sep 17, 2008

A federal appeals court has refused to revisit its July order that overturned a ruling allowing Nokia Corp. to take its patent spat with InterDigital Inc. over mobile handsets to arbitration, according to InterDigital.

18. LG Electronics, Whirlpool Partially Settle IP Actions

Thursday, Sep 11, 2008

Whirlpool Corp. and LG Electronics USA Inc. have reached a partial agreement to dismiss several claims and counterclaims in their feud over patents for popular refrigerator and freezer designs in two separate proceedings.

19. Institut Pasteur Tries To Block New Novartis Theory

Tuesday, Sep 09, 2008

Two French research organizations have asked a federal court to prevent a Novartis AG subsidiary from presenting new legal theories for its priority claim in a three-way battle over rights to a patent covering technology for detecting HIV in blood.

20. Medtronic Can Add Claims, But Stent Trial Bumped

Wednesday, Sep 03, 2008

Medtronic Inc. will be allowed to add patent infringement claims against Boston Scientific Corp. in an ongoing lawsuit over the Promus stent, but it won't get the January trial date it wanted after a federal judge decided more time was needed to deal with damages-related issues.